MET stock forecast: what analysts expect
Wall Street analysts covering MetLife, Inc. currently rate the stock a Buy on average, with a mean 12-month price target of $103.69 — +7.3% versus the last price of $96.66. Targets reflect analyst opinion, not a guarantee.
MET historical returns
Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in MET.
MET annual returns by year
Congress trading in MET
14 members of Congress have disclosed trading MET — 15 purchases and 14 sales worth an estimated $281,000. Most recent disclosure: Aug 3, 2022.
See who in Congress traded MET →Insider activity in MET
MET's own executives and directors have made 0 open-market purchases ($0) and 1 sale ($1.7M) in the last 90 days, per SEC Form 4 filings. Most recent: Jun 1, 2026.
| Jun 1, 2026 | Debel Marlene | EVP & Chief Risk Officer | Sell | $1.7M |
About MetLife, Inc.
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.
MET Key Statistics
MET in plain English
- P/E ratio (18.6) — how many dollars you pay for each $1 of MET's yearly profit. That's a fairly normal range.
- ROE (13.09%) — how efficiently the company turns shareholders' money into profit. This is a middling level.
- Profit margin (4.57%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend yield (2.45%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.
MET stock: frequently asked questions
What is MetLife, Inc.'s stock price today?
MetLife, Inc. (MET) last traded at $96.66 on the NYSE. Over the past 52 weeks the stock has traded between $67.33 and $100.93.
Is MET stock a buy or a sell?
Wall Street analysts' consensus rating on MET is "Buy", with an average 12-month price target of $103.69 — about +7.3% versus the current price of $96.66. Analyst targets are opinions, not guarantees; always do your own research.
How much would $1,000 invested in MET 10 years ago be worth today?
A $1,000 investment in MetLife, Inc. made 10 years ago would be worth about $3,491 today (dividends reinvested) — a total return of 249%, or 13.3% per year.
Does MET pay a dividend?
Yes. MetLife, Inc. currently pays a dividend yielding about 2.45% per year at today's share price.
What is MET's P/E ratio?
MET trades at a trailing price-to-earnings ratio of 18.6, and 8.9 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.
Do members of Congress trade MET stock?
Yes — 14 members of Congress have disclosed trades in MET under the STOCK Act, totaling 15 purchases and 14 sales worth an estimated $281,000.
What is MetLife, Inc.'s ticker symbol?
MetLife, Inc. trades under the ticker symbol MET on the NYSE.
Compare MET with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.